Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.

Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.

Item
http://www.wikidata.org/entity/Q39220127
Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.CHK1 expression in Gastric Cancer is modulated by p53 and RB1/E2F1: implications in chemo/radiotherapy response.Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel.AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel.E1a promotes c-Myc-dependent replicative stress: implications in glioblastoma radiosensitization.Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways.Characteristics of doxorubicin-selected multidrug-resistant human leukemia HL-60 cells with tolerance to arsenic trioxide and contribution of leukemia stem cells.Using phosphine ligands with a biological role to modulate reactivity in novel platinum complexes.CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest.XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
P2860

Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.

Item
http://www.wikidata.org/entity/Q39220127
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@en
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@nl
type
label
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@en
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@nl
prefLabel
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@en
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921